M-021001 cell therapy

N/A

Report date: 2024/07/30 15:14:38

Base Information

Drug NameM-021001 cell therapy
Drug Alias NameM-021001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsMeniscus Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInstitute Of Zoology, Chinese Academy Of SciencesBeijing Zehui Chenxing Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesInstitute Of Zoology, Chinese Academy Of SciencesBeijing Zehui Chenxing Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMeniscus Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A